Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study. (Q33373965)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

24 December 2019

main subject

0 references

thrombocytopenia

1 reference

based on heuristic

inferred from title

thrombotic thrombocytopenic purpura

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Emin Kaya

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

M Cetin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Ismet Aydogdu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Sibel Kabukcu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Kerim Cikim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ismail Sari

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

M Ali Erkut

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Bulent Eser

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ahmet Ozturk

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ali Keskin

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Ali Unal

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Fevzi Altuntas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

19 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

Transfusion and Apheresis Science

24 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

57-67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17240195%20AND%20SRC:MED&resulttype=core&format=json

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

24 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic Microangiopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Severe thrombotic microangiopathy associated with brucellosis: successful treatment with plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura associated with clopidogrel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura and systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura: early and late responders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Increasing mortality from thrombotic thrombocytopenic purpura in the United States--analysis of national mortality data, 1968-1991.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Intravenous cyclophosphamide therapy in a case with refractory thrombotic microangiopathic hemolytic anemia and SLE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Splenectomy for the treatment of thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Treatment of resistant thrombotic thrombocytopenic purpura with rituximab and cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Successful treatment of thrombotic thrombocytopenic purpura with high-dose corticosteroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Efficacy of intravenous immunoglobulin in the treatment of thrombotic thrombocytopaenic purpura. A study of 44 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenia purpura: a single institution experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura: 24 years of experience at the American University of Beirut Medical Center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Possibilities and limits of treatment in patients with thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Response to plasma exchange and steroids as combined therapy for patients with thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura (TTP): initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

High-dose intravenous methylprednisolone for thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Rituximab therapy for refractory thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic microangiopathies associated with drugs and bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014

THROMBOTIC THROMBOCYTOPENIC PURPURA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2006.05.014